These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37147783)

  • 41. Low density lipoprotein-inspired nanostructured lipid nanoparticles containing pro-doxorubicin to enhance tumor-targeted therapeutic efficiency.
    Li W; Fu J; Ding Y; Liu D; Jia N; Chen D; Hu H
    Acta Biomater; 2019 Sep; 96():456-467. PubMed ID: 31260821
    [TBL] [Abstract][Full Text] [Related]  

  • 42.
    Dong Y; Du P; Liu P
    Int J Pharm; 2020 Oct; 588():119723. PubMed ID: 32755688
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transformable prodrug nanoplatform
    Yang W; Yi J; Zhu R; Guo Y; Zhang K; Cao Y; Li X; Zhang J; Zhang Z; Li Y; Chen X
    Theranostics; 2023; 13(6):1906-1920. PubMed ID: 37064869
    [No Abstract]   [Full Text] [Related]  

  • 44. Fabricating an intelligent cell-like nano-prodrug via hierarchical self-assembly based on the DNA skeleton for suppressing lung metastasis of breast cancer.
    Li Y; Yan T; Chang W; Cao C; Deng D
    Biomater Sci; 2019 Aug; 7(9):3652-3661. PubMed ID: 31169833
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fluorescent hyaluronic acid nanoprodrug: A tumor-activated autophagy inhibitor for synergistic cancer therapy.
    Wu Y; Liu X; Yao C; Chen J; Wu X; Zhu M
    Int J Biol Macromol; 2024 Aug; 274(Pt 1):133360. PubMed ID: 38909736
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dual-prodrug cascade activation for chemo/chemodynamic mutually beneficial combination cancer therapy.
    Zhang X; Guo H; Zhang X; Shi X; Yu P; Jia S; Cao C; Wang S; Chang J
    Biomater Sci; 2023 Jan; 11(3):1066-1074. PubMed ID: 36562486
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In situ Injection of pH- and Temperature-Sensitive Nanomaterials Increases Chemo-Photothermal Efficacy by Alleviating the Tumor Immunosuppressive Microenvironment.
    Liu J; Guo L; Rao Y; Zheng W; Gao D; Zhang J; Luo L; Kuang X; Sukumar S; Tu Y; Chen C; Sun S
    Int J Nanomedicine; 2022; 17():2661-2678. PubMed ID: 35733417
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Self-Indicating Polymer Prodrug Nanoparticles for pH-Responsive Drug Delivery in Cancer Cells and Real-Time Monitoring of Drug Release.
    Kayal S; Kola P; Pal J; Mandal M; Dhara D
    ACS Appl Bio Mater; 2024 Sep; 7(9):5810-5822. PubMed ID: 39186444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dual-Loaded Liposomes Tagged with Hyaluronic Acid Have Synergistic Effects in Triple-Negative Breast Cancer.
    Dong S; Bi Y; Sun X; Zhao Y; Sun R; Hao F; Sun Y; Wang Y; Li X; Deng W; Liu X; Ha J; Teng L; Gong P; Xie J; Kim BYS; Yang Z; Jiang W; Teng L
    Small; 2022 Apr; 18(16):e2107690. PubMed ID: 35277914
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tandem Chemoimmunotherapy by a Cascade-Responsive Molecular Prodrug.
    Yang Z; Luo X; Lin Y; Huang J; Lin H; Gao J
    ACS Chem Biol; 2022 Apr; 17(4):762-767. PubMed ID: 35285234
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pronounced antitumor efficacy of doxorubicin when given as the prodrug DOX-GA3 in combination with a monoclonal antibody beta-glucuronidase conjugate.
    Houba PH; Boven E; van der Meulen-Muileman IH; Leenders RG; Scheeren JW; Pinedo HM; Haisma HJ
    Int J Cancer; 2001 Feb; 91(4):550-4. PubMed ID: 11251980
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening of pH-responsive long-circulating polysaccharide-drug conjugate nanocarriers for antitumor applications.
    Zhang X; Li D; Huang J; Ou K; Yan B; Shi F; Zhang J; Zhang J; Pang J; Kang Y; Wu J
    J Mater Chem B; 2019 Jan; 7(2):251-264. PubMed ID: 32254550
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dual ATP and pH responsive ZIF-90 nanosystem with favorable biocompatibility and facile post-modification improves therapeutic outcomes of triple negative breast cancer in vivo.
    Jiang Z; Wang Y; Sun L; Yuan B; Tian Y; Xiang L; Li Y; Li Y; Li J; Wu A
    Biomaterials; 2019 Mar; 197():41-50. PubMed ID: 30640136
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dual stimuli-responsive dendronized prodrug derived from poly(oligo-(ethylene glycol) methacrylate)-based copolymers for enhanced anti-cancer therapeutic effect.
    Luo Q; Lin L; Huang Q; Duan Z; Gu L; Zhang H; Gu Z; Gong Q; Luo K
    Acta Biomater; 2022 Apr; 143():320-332. PubMed ID: 35235863
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rapid pH-responsive self-disintegrating nanoassemblies balance tumor accumulation and penetration for enhanced anti-breast cancer therapy.
    Li J; Wang Y; Xu C; Yu Q; Wang X; Xie H; Tian L; Qiu Y; Guo R; Lu Z; Li M; He Q
    Acta Biomater; 2021 Oct; 134():546-558. PubMed ID: 33882357
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stimuli-responsive polymer-doxorubicin conjugate: Antitumor mechanism and potential as nano-prodrug.
    Chen K; Cai H; Zhang H; Zhu H; Gu Z; Gong Q; Luo K
    Acta Biomater; 2019 Jan; 84():339-355. PubMed ID: 30503561
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhanced Penetrability of a Tetrahedral Framework Nucleic Acid by Modification with iRGD for DOX-Targeted Delivery to Triple-Negative Breast Cancer.
    Liu M; Ma W; Zhao D; Li J; Li Q; Liu Y; Hao L; Lin Y
    ACS Appl Mater Interfaces; 2021 Jun; 13(22):25825-25835. PubMed ID: 34038071
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stimuli-Sensitive Linear-Dendritic Block Copolymer-Drug Prodrug as a Nanoplatform for Tumor Combination Therapy.
    Cai H; Tan P; Chen X; Kopytynski M; Pan D; Zheng X; Gu L; Gong Q; Tian X; Gu Z; Zhang H; Chen R; Luo K
    Adv Mater; 2022 Feb; 34(8):e2108049. PubMed ID: 34875724
    [TBL] [Abstract][Full Text] [Related]  

  • 59. pH-Responsive prodrug nanoparticles based on a sodium alginate derivative for selective co-release of doxorubicin and curcumin into tumor cells.
    Gao C; Tang F; Gong G; Zhang J; Hoi MPM; Lee SMY; Wang R
    Nanoscale; 2017 Aug; 9(34):12533-12542. PubMed ID: 28819666
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Doxorubicin prodrug-based nanomedicines for the treatment of cancer.
    Zhao H; Yu J; Zhang R; Chen P; Jiang H; Yu W
    Eur J Med Chem; 2023 Oct; 258():115612. PubMed ID: 37441851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.